Litigation Funding Returns: Realistic Numbers
Litigation funding returns can look impressive on a fund factsheet — but what do realistic net multiples, hold periods, and loss rates actually look like for an investor who is not running a nine-figure portfolio?
Why Litigation Funding Returns Are Hard to Benchmark
Unlike listed equities or bond indices, litigation funding has no standardised public data set. Most large funders — Burford Capital, Omni Bridgeway, Litigation Capital Management — publish some portfolio metrics, but they measure performance differently: gross versus net multiples, realised versus unrealised, single-case versus portfolio. That inconsistency makes headline comparisons unreliable. What we do know is that the asset class is genuinely uncorrelated to equity markets. A recession does not make a patent-infringement claim worth less; a rate hike does not extend discovery timelines. That structural independence is a real feature, but it does not mean the returns are guaranteed. Understanding the mechanics behind the numbers is the only way to set honest expectations before you commit capital.
Typical Litigation Funding Returns: Multiples and IRR Ranges
Industry data points — drawn from public filings by listed funders and academic studies such as those published by the Journal of Alternative Investments — cluster around gross returns of 2.0x to 4.0x invested capital on winning cases, before fees and expenses. After manager fees (typically 20–30 % of profits or a share of proceeds), net multiples to the capital provider have historically ranged from roughly 1.5x to 2.5x on resolved cases. Converted to IRR, that range translates to approximately 15–35 % per annum depending on duration. These are not guaranteed figures; they represent the central tendency of reported results on cases that settled or won. They tell you nothing about the cases that lost. We address that next.
Loss Rates: The Number Most Pitch Decks Bury
Professional funders typically lose between 20 % and 40 % of the cases they back, depending on case type and jurisdiction. Commercial arbitration tends to have somewhat lower loss rates than domestic litigation; mass tort portfolios are more complex to assess. A single-case investment that loses returns zero — full stop. There is no recovery of principal, no interest, no consolation prize. This binary outcome is the most important structural risk to internalise. Diversified portfolios of 20-plus cases smooth this out considerably: a 30 % loss rate across a well-underwritten portfolio of 25 cases still produces strong aggregate returns if the winning cases deliver adequate multiples. Single-case or two-case exposure carries meaningful concentration risk that retail-adjacent investors frequently underestimate.
Duration: How Long Is Your Capital Actually Locked Up?
Litigation takes time. Average case duration across commercial funders' disclosed portfolios runs between 2 and 4 years from funding to resolution, but individual cases can stretch to 7 years or more, especially when appeals are pursued. That lock-up has a direct impact on IRR even when the nominal multiple looks attractive: a 2.0x return over 2 years is a very different investment from a 2.0x return over 5 years. Investors should model duration pessimistically — assume the upper end of the range — and ensure they have no liquidity need against that capital during the period. Some tokenised litigation finance structures, including those facilitated on regulated platforms in jurisdictions like Liechtenstein, are beginning to introduce secondary market bulletin boards that allow position transfers, though liquidity remains limited and should not be relied upon.
How Tokenisation Changes the Access Equation
Historically, direct participation in litigation finance was reserved for institutional allocators writing cheques of USD 5 million or more. Tokenisation under frameworks such as Liechtenstein's Token and Trusted Technology Service Provider Act (TVTG) enables regulated issuers to fractionise a litigation funding interest into digital securities, lowering minimum investment thresholds substantially. On a platform like Investhub, which supports TVTG-compliant token issuance and stablecoin settlement, an investor can access a diversified litigation finance exposure that would previously have required institutional scale. This structural shift does not change the underlying return profile — the case either wins or it does not — but it does change who can access the asset class and on what terms. Compliance infrastructure, custody standards, and issuer due diligence remain as important as ever.
What a Realistic Portfolio Scenario Looks Like
Consider a hypothetical portfolio of 10 litigation funding positions with equal capital allocation. Assume a 30 % loss rate (3 cases return zero), average duration of 3 years, and a gross 2.5x multiple on winning cases. The aggregate gross return across the portfolio is 7 × 2.5x = 17.5 units recovered on 10 units invested — a gross portfolio multiple of 1.75x over roughly 3 years, equating to approximately 20 % gross IRR. After a 25 % profit share to the manager, net IRR to the investor falls to roughly 14–16 %. That is a plausible, evidence-based scenario — not a guarantee, not a worst case. Actual results will vary based on underwriting quality, jurisdiction, case type, manager skill, and macroeconomic factors affecting settlement behaviour.
Key Risks Every Investor Must Acknowledge
Beyond the headline numbers, litigation funding carries risks that deserve explicit naming. First, adverse judgments: courts are unpredictable, and even well-underwritten claims fail. Second, duration extension risk: appeals, procedural delays, and enforcement proceedings can extend timelines materially. Third, adverse costs orders: in some common-law jurisdictions, a losing claimant may be ordered to pay the defendant's legal costs, eroding the funder's capital further. Fourth, manager quality: underwriting discipline varies enormously between funders; past portfolio performance is not a reliable predictor of future results on a new portfolio. Fifth, regulatory and enforceability risk: champerty and maintenance laws in certain jurisdictions may affect enforceability of funding agreements. Diligence on the specific issuer and legal structure is non-negotiable.
Key Takeaways
- Gross multiples on winning cases typically range from 2.0x to 4.0x; net to investors after fees is roughly 1.5x to 2.5x.
- Loss rates of 20–40 % are normal in professional portfolios — single-case investments carry full binary risk.
- Average case duration is 2–4 years, but outliers exceeding 7 years are common; model pessimistically.
- Tokenisation under regulated frameworks like Liechtenstein's TVTG is opening the asset class to non-institutional investors at lower minimums.
FAQ
What is a typical return multiple for litigation funding?
On resolved, winning cases, gross multiples reported by professional funders typically fall between 2.0x and 4.0x of invested capital. After management fees and profit shares, net multiples to investors have historically ranged from approximately 1.5x to 2.5x. These figures apply only to cases that succeeded; losing cases return zero principal.
How long does a litigation funding investment take to pay out?
Most commercial litigation funding positions resolve in 2 to 4 years, though complex international arbitrations or heavily appealed cases can take 6 to 7 years or more. Duration risk directly compresses IRR even when the nominal multiple is attractive, so investors should plan for capital to be illiquid for the upper end of that range.
What happens if the funded case loses?
Litigation funding is non-recourse: if the case loses, the investor recovers nothing. There is no return of principal, no interest payment, and no partial recovery. This binary outcome is the central risk of the asset class and the main reason diversification across multiple cases — rather than single-case concentration — is strongly recommended.
Is litigation funding correlated with the stock market?
Structural correlation to public equity markets is very low. Case outcomes depend on legal merits, judicial discretion, and settlement dynamics — not on interest rates or GDP growth. This makes litigation finance attractive as a portfolio diversifier, though investors should note it is illiquid and carries its own idiosyncratic risks unrelated to macro conditions.
Can retail or semi-professional investors access litigation funding?
Traditionally, direct litigation finance was institutional-only, requiring multi-million-dollar minimums. Regulated tokenisation frameworks — such as Liechtenstein's TVTG — now allow issuers to fractionise litigation finance interests into digital securities. Platforms like Investhub support such issuances with compliant infrastructure, lowering the access threshold significantly while maintaining regulatory standards.
What fees do litigation funders charge?
Fee structures vary but commonly include a profit share of 20–30 % of net proceeds, a multiple-of-invested-capital hurdle (e.g. the funder keeps the higher of 3x capital or 30 % of proceeds), or a hybrid of both. Some fund structures also charge annual management fees of 1–2 %. Investors should model fees explicitly — they have a material impact on net returns.
Litigation funding returns can be genuinely attractive — but only when you price in the loss rates, the duration, and the fee drag that pitch decks tend to minimise. The realistic net IRR for a well-diversified, professionally managed portfolio sits in the mid-teens to low twenties on a percentage basis: compelling as an alternative allocation, not a miracle. If you are exploring regulated access to this asset class through tokenised structures, Investhub's compliant issuance infrastructure in Liechtenstein is worth understanding before you make a decision. Start with the numbers — then evaluate the legal wrapper.